## Abstract Cytokines and neuropeptides are modulators of neuroimmunoregulation in the central nervous system (CNS). The interaction of these modulators may have important implications in CNS diseases. We investigated whether interleukin‐1β (IL‐1β) modulates the expression of neurokinin‐1 receptor
Morphine upregulates functional expression of neurokinin-1 receptor in neurons
✍ Scribed by Qi Wan; Steven D. Douglas; Xu Wang; Dennis L. Kolson; Lauren A. O'Donnell; Wen-Zhe Ho
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 351 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Neuronkinin‐1 receptor (NK‐1R), the neuropeptide substance P (SP) preferring receptor, is highly expressed in areas of the central nervous system (CNS) that are especially implicated in depression, anxiety, and stress. Repeated exposure to opioids may sensitize neuronal systems involved in stress response. We examined the effects of morphine, the principal metabolite of heroin, on the functional expression of NK‐1R in the cortical neurons. NK‐1R and mu‐opioid receptor (MOR) are co‐expressed in the cortical neurons. Morphine enhanced NK‐1R expression in the cortical neurons at both the mRNA and protein levels. The upregulated NK‐1R by morphine had functional activity, because morphine‐treated cortical neurons had greater SP‐induced Ca^2+^ mobilization than untreated neurons. Blocking opioid receptors on the cortical neurons by naltrexone or CTAP (a μ‐opioid receptor antagonist) abolished the morphine action. Investigation of the mechanism(s) responsible for the morphine action showed that morphine activated NK‐1R promoter and induced the phosphorylation of p38 MAPK protein in the cortical neurons. These in vitro data provide a plausible cellular mechanism for opioid‐mediated neurological disorders. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Tachykinin (TK) peptides act on retinal neurons through neurokinin (NK) receptors. We examined the expression of neurokinin-1 (NK1; the substance P receptor), NK3 [the neurokinin B (NKB) receptor], and TK peptides in developing rat retinas. NK1 immunolabeling was found in newborn retinas in rare ama
## Abstract Substance P (SP), the most extensively studied and potent member of the tachykinin family, is a major modulator of inflammation and immunomodulatory activities within the central and peripheral nervous systems. We have examined the gene expression of SP and its receptor in a human neuro
Nerve growth factor (NGF) initiates its biological effects by promoting the dimerization and activation of the tyrosine kinase receptor TrkA. The requirements for NGF signaling through the TrkA receptor have been defined extensively from studies in immortalized cells, involving transfection of NIH 3
## Abstract The basic helix loop helix‐PAS (bHLH‐PAS) transcription factors have diverse roles in physiologic responses to the environment and in early development. One bHLH‐PAS protein, neuronal PAS domain protein 1 (NPAS1), is reported to be expressed only in the central nervous system beginning
Extracellular-signal-regulated kinases (ERKs) were described originally as critical regulators of cell growth and differentiation. ERKs have received increasing attention as important regulators of neuronal function, especially in synaptic plasticity and memory. We found a group of phospho-ERK1/2 (p